Cargando…

Author Correction: Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study

Detalles Bibliográficos
Autores principales:	Al Sulaiman, Khalid, Aljuhani, Ohoud, Saleh, Khalid Bin, Badreldin, Hisham A., Al Harthi, Abdullah, Alenazi, Mohammed, Alharbi, Aisha, Algarni, Rahmah, Al Harbi, Shmeylan, Alhammad, Abdullah M., Vishwakarma, Ramesh, Aldekhyl, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461440/ https://www.ncbi.nlm.nih.gov/pubmed/34561522 http://dx.doi.org/10.1038/s41598-021-99146-7

Ejemplares similares

Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: a two center propensity-score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
por: Aljuhani, Ohoud, et al.
Publicado: (2021)

Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study
por: Al Sulaiman, Khalid A., et al.
Publicado: (2021)

The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patient
por: Harbi, Shmeylan Al, et al.
Publicado: (2022)

Clinical Pharmacy Faculty Provision of Direct Patient Care, Challenges, and Opportunities
por: Korayem, Ghazwa B., et al.
Publicado: (2023)

Comparison between standard Vs. Escalated dose venous thromboembolism (VTE) prophylaxis in critically ill patients with COVID-19: A two centers, observational study
por: Aljuhani, Ohoud, et al.
Publicado: (2022)

Therapeutic Plasma Exchange and Supratherapeutic Levels of Unfractionated Heparin in the Management of Critically Ill Patient with Myasthenia Gravis: A Case Report
por: Alshehri, Shaden D., et al.
Publicado: (2022)

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study
por: Saleh, Khalid Bin, et al.
Publicado: (2021)

The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study
por: Aljuhani, Ohoud, et al.
Publicado: (2023)

Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study – New-Onset Atrial Fibrillation and COVID-19
por: Kensara, Raed, et al.
Publicado: (2023)

Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study
por: Al Harbi, Shmeylan, et al.
Publicado: (2022)

The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study
por: Korayem, Ghazwa B., et al.
Publicado: (2022)

Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational Study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Apixaban Use in Patients with Protein C and S Deficiency: A Case Series and Review of Literature
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021)

Assessing the Perception of Pharmacy Students on Launching a Doctor of Pharmacy/Master of Public Health Dual Degree Program in Saudi Arabia: A Multi-Institutional Cross-Sectional Study
por: Badreldin, Hisham A., et al.
Publicado: (2022)

Characteristics of Critical Care Pharmacy Services in Saudi Arabia
por: Ismail, Nadia H, et al.
Publicado: (2023)

Practical Guide for Anticoagulant and Antiplatelet Reversal in Clinical Practice
por: Aldhaeefi, Mohammed, et al.
Publicado: (2023)

Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Correction: The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

The clinical outcomes of COVID-19 critically ill patients co-infected with other respiratory viruses: a multicenter, cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19—A multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Management of asthma exacerbation in the emergency departments
por: Al-Shamrani, Abdullah, et al.
Publicado: (2019)

Wheezing in children: Approaches to diagnosis and management
por: Al-Shamrani, Abdullah, et al.
Publicado: (2019)

The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective study
por: Sulaiman, Khalid Al, et al.
Publicado: (2022)

What the near Future Holds for Sacubitril/Valsartan: A Summary of Major Ongoing Studies
por: Badreldin, Hisham A., et al.
Publicado: (2022)

Association between β-blocker use and mortality in critically ill patients: a nested cohort study
por: Al Harbi, Shmeylan A., et al.
Publicado: (2018)

Clonidine safety and effectiveness in the management of suspected paroxysmal sympathetic hyperactivity post-traumatic brain injury: A retrospective cohort study
por: Alshaya, Abdulrahman I, et al.
Publicado: (2023)

Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

When antivirals backfire: An evaluation of favipiravir’s clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hf9kgnal5i738j4v552aphju5g